Results 131 to 140 of about 2,220 (157)

Acute nonlymphocytic leukemias following chemotherapy. Ultrastructural study of erythroblastic cell line and discussion of nuclear anomalies.

Blood cells, 1982
In 18 cases of drug-induced acute leukemia, electron microscopy brought out a number of anomalies found in all hematopoietic cell lines. They are described here for the erythroblastic line. Some of these anomalies occur in the cytoplasm (like siderosomes, iron-containing mitochondria, glycogen spots, various dense inclusions, and nuclear-cytoplasmic ...
J P, Thiery, A, Aurias, J, Dumont, A, Mazabraud, P, Trapet   +4 more
openaire   +1 more source

Kinetic behavior of 'pathological' myeloblasts and 'normal' erythroblasts in acute granulocytic leukemia. Analysis of in vitro studies in 20 patients.

Oncology, 1983
Kinetic studies of leukemic blast cells (LBC) and erythroblasts were carried out in 20 cases of acute myeloblastic leukemia (AML), and the results were compared with those observed in dividing granulocytic precursors (DGP) and erythroblasts in a control group of 16 normal subjects.
J, Sánchez-Fayos, J, Outeiriño, J M, Fernández-Rañada, M T, Calabuig   +3 more
openaire   +1 more source

[Poor response in patients with de novo acute myeloid leukemia and erythroblastic or megakaryocytic dysplasia to treatment with standard doses of cytosine arabinoside and daunorubicin].

Vnitrni lekarstvi, 2000
Erythroid and/or megakaryocytic dysplasia (EMD) was evaluated in diagnostic bone marrow smears of 37 consecutively treated cases with de novo acute myeloid leukemia (AML) M0-M2 and M4-M5 types and three newly diagnosed cases of refractory anaemia with excess of blasts in transformation.
P, Lemez, J, Gáliková, T, Haas
openaire   +1 more source

Do de novo acute myeloid leukemias with normal cytogenetics involve two main prognostic categories distinguished by the presence of erythroblastic and/or megakaryocytic dysplasia?

Neoplasma, 2000
De novo acute myeloid leukemias (AML) patients with normal cytogenetics represent a standard risk cytogenetic group. Erythroblastic and/or megakaryocytic dysplasia (EMD) in diagnostic bone marrow smears of 28 consecutive AML patients with a normal karyotype was studied.
P, Lemez, J, Gáliková, T, Haas
openaire   +1 more source

[Patients older than 80 years with de novo acute myeloid leukemias without erythroblastic and/or megakaryocytic dysplasia achieve complete remission and longer survival after classical chemotherapy 3 + 7].

Vnitrni lekarstvi, 2010
Chemotherapy in most patients with AML over 80 years of age is not recommended because their median survival is about 1 month. The aim of our study was to identify patients in this age group who might achieve complete remission with standard dose chemotherapy. We report 9 consecutive patients with de novo AML diagnosed and treated in 1992-2008.
P, Lemez, J, Gáliková, K, Michalová, D, Dvoráková, A, MacWhannell, Z, Zemanová, J, Stejskal   +6 more
openaire   +1 more source

Isochromosome 11q in acute erythroblastic leukemia

Leukemia Research, 1992
openaire   +2 more sources

Acute leukemia in adults: recent developments in diagnosis and treatment

Ca-A Cancer Journal for Clinicians, 1994
S M Devine, Richard A Larson, Steven M Devine   +2 more
exaly  

CIC‐Rearrangements in Pediatric Acute Erythroid Leukemia/Erythroblastic Sarcoma

Pediatric Blood & Cancer
Alexandra L. Chang‐Graham, Thien Nguyen, Jean Oak, Oscar Silva, Tanja A. Gruber   +4 more
openaire   +2 more sources

The Difficult Problem of Acute Myeloid Leukemia in the Older Adult

Ca-A Cancer Journal for Clinicians, 2002
R M Stone, Richard M Stone
exaly  

Treatment of Acute Leukemia:: Current Results, and Analysis of What We Can Do Now

Ca-A Cancer Journal for Clinicians, 1964
Margaret P Sullivan, W W Sutow, Wataru W Sutow   +2 more
exaly